Lates News

date
07/08/2025
Novo Nordisk has stated that it expects full-year free cash flow to reach 35 to 45 billion Danish kroner. It is expected that the ratio of capital expenditures to sales in the coming years will remain in the low double-digit range.
Latest
See all latestmore